Skip to main content

Advertisement

Fig. 1 | Health and Quality of Life Outcomes

Fig. 1

From: Evaluation of the impact of once weekly dulaglutide on patient-reported outcomes in Japanese patients with type 2 diabetes: comparisons with liraglutide, insulin glargine, and placebo in two randomized studies

Fig. 1

Study Design for the Monotherapy Study. D/E diet and exercise; I Injectable Diabetes Medication Questionnaire - Japanese version; LV30 follow-up visit 30 days after last study visit; OHA oral hypoglycemic agent; P Perceptions About Medications-Diabetes 21 Questionnaire - Japanese version; PRO Patient-Reported Outcomes

Back to article page